The potential role of tissue factor in regulating haemostasis, thrombosis and angiogenesis in human endometrium

Reproductive Medicine Review

Volumn 9, Issue 2, 2001, Pages 119-139

  Schatz, F ^a   Krikun, G ^a   Lockwood, C J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; COLLAGENASE; CONTRACEPTIVE AGENT; CYTOKINE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FIBRONECTIN; GELATINASE B; GESTAGEN; LEVONORGESTREL; MATRIX METALLOPROTEINASE; MEDROXYPROGESTERONE ACETATE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; STROMELYSIN; THROMBIN; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; BLOOD CLOTTING; DECIDUA; DECIDUALIZATION; DRUG INDUCED DISEASE; ENDOMETRIUM; ENDOTHELIUM CELL; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; HEMOSTASIS; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATION; MENSTRUATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; STROMA CELL; THROMBOSIS; UTERUS BLEEDING;

EID: 0035726229     PISSN: 09622799     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0962279901000230     Document Type: Review

References (116)

1. Decidualization and relevance to menstruation
2. Interactions of the trophoblast and maternal tissues in three closely related primate species
3. Ultrastructure of the spiral arteries in the human placental bed at the end of normal pregnancy
4. Early embryonic mortality in women
5. Fetal loss after implantation. A prospective study
6. Massive subchorial thrombohaematoma (Breus' mole)
7. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization
8. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using NORPLANT-2 contraception
9. Tissue factor and hemostasis
10. Affinity purification of human tissue factor: Interaction of factor VII and tissue factor in detergent micelles
11. Initiation of coagulation by tissue factor
12. Activation and control of factor VII by activated factor X and thrombin
13. Activation of human factor VII by activated factors IX and X
14. Biology and biochemistry of proteinases in tumor invasion
15. Role of tissue factor in embryonic blood vessel development
16. Low levels of tissue factor are compatible with development and hemostasis in mice
17. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation
18. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation
19. Plasminogen activators in endometrial physiology and embryo implantation: A review
20. Immunochemical and ultrastructural assessment of the nature of the pericellular basement membrane of human decidual cells
21. Cellular biology of the endometrium
22. Laminins 2 and 4 are expressed by human decidual cells
23. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones
24. Menstruation: Induction by matrix metalloproteinases and inflammatory cells
25. Decidual stromal cell-lymphocyte interactions in pregnancy
26. Trophoblast invasion
27. Morphological basis for menstrual bleeding
28. Cyclic changes in endometrial tissue plasminogen activator and tissue plasminogen activator type 1 in women with normal menstruation and essential menorrhagia
29. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding
30. Thrombin effects on steroid-modulated endometrial stromal cell fibrinolytic potential
31. Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells
32. Insulin-like growth factor binding proteins in human endometrium: Steroid-dependent messenger ribonucleic acid expression and protein synthesis
33. Regulation of insulin-like growth factor-binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells
34. Hormonal regulation of human endometrial stromal cells in culture: An in vitro model for decidualization
35. Progestin stimulates the biosynthesis of fibronectin and accumulation of fibronectin mRNA in human endometrial stromal cells
36. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells
37. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium
38. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal
39. Production of endometrial matrix metalloproteinases but not their tissue inhibitors is modulated by progesterone withdrawal in an in vitro model for menstruation
40. Plasminogen activators in the human endometrium, cellular origin and hormonal regulation
41. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1
42. Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells
43. Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells
44. Estradiol and progesterone receptor concentrations and 17β-hydroxysteroid-dehydrogenase activity in estrogen-progestin stimulated endometrium of women with gonadal dysgenesis
45. Human endometrial cells in primary tissue culture: Modulation of the progesterone receptor level by natural and synthetic estrogens in vitro
46. Steroid-modulated stromal cell tissue factor expression: A model for the regulation of endometrial hemostasis and menstruation
47. Biological mechanisms underlying RU 486 clinical effects: Inhibition of endometrial stromal cell tissue factor content
48. Biological mechanisms underlying the clinical effects of RU 486: Modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression
49. Biological mechanisms underlying RU 486 clinical effects: Modulation of endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression
50. Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by SP1 and EGR-1
51. Lipopolysaccharide induction of tissue factor expression in THP-1 monocytic cells, protein-DNA interactions with the promoter
52. Tissue Factor gene transcription in serum-stimulated fibroblasts is mediated by recruitment of c-fos into specific AP-1 DNA-binding complexes
53. Thrombin induces thromboplastin synthesis in cultured vascular endothelial cells
54. Thrombin regulates tissue factor and thrombomodulin mRNA level and activities in human saphenous vein endothelial cells by distinct mechanisms
55. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers
56. Regulation of the tissue factor gene
57. Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells
58. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3
59. Proliferation of mouse uterine epithelial cells in vitro
60. Epidermal growth factor receptor replaces estrogen in the stimulation of female genital tract growth and differentiation
61. Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid
62. Sex steroids and growth factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells
63. Receptor for epidermal growth factor and other polypeptide mitogens
64. The autocrine loop of TGFa/EGFR and brain tumors
65. Specificity within the EGF family/ErbB receptor family signaling network
66. Progestin-epidermal growth factor interactions regulate plasminogen activator inhibitor-1 expression during decidualization of human endometrial stromal cells
67. Progestin-epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells
68. Changes in epidermal growth factor receptor and levels of its ligands during menstrual cycle in human endometrium
69. Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female reproductive tract and in the placenta
70. Cyclic adenosine 3′ 5′-monophosphate induces prolactin expression in stromal cells isolated from human proliferative endometrium
71. Interferon-γ modulates prolactin and tissue factor expression in differentiating human endometrial stromal cells
72. Activation of c-Src kinase is associated with in vitro decidualization of human endometrial stromal cells
73. Cellular functions regulated by Src family kinases
74. Cardiovascular disease and steroid hormone contraception
75. Bleeding patterns in NORPLANT contraceptive implant users
76. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use
77. Three-year experience with NORPLANT subdermal contraception
78. A 5-year evaluation of NORPLANT contraceptive implants in China
79. Effects of norplant on endometrial tissue factor expression and angiogenesis
80. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system
81. The role of tissue factor in regulating endometrial haemostasis: Implications for progestin only contraception
82. Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis
83. Endothelial cells in physiology and in the pathophysiology of vascular disorders
84. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment
85. Human endometrial endothelial cells: Isolation, characterization and inflammatory-mediated expression of tissue factor and type 1 plasminogen activator inhibitor
86. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors
87. Angiogenesis, vascular endothelial growth factor and the endometrium
88. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta
89. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
90. In vivo angiogenic activity and hypoxia induction of heterodimers of placental growth factor/vascular endothelial growth factor
91. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
92. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
93. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation
94. Tissue factor expression in human endometrial cells: Implications for uteroplacental thrombosis
95. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: Potential relevance to menstruation and endometrial regeneration
96. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia
97. Endometrial morphology during the normal cycle and under the influence of contraceptive steroids
98. Endometrial vasculature in NORPLANT users
99. Endometrial vasculature in NORPLANT users: Preliminary results from a hysteroscopic study
100. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel
101. Tissue factor
102. The angiogenic effect of tissue factor on tumors and wounds
103. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII
104. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor
105. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium
106. Cooperation between VEGF and TNF-a is necessary for exposure of active tissue factor on the surface of human endothelial cells
107. Polar expression of tissue factor in human umbilical vein endothelial cells
108. An endothelial cell-dependent pathway of coagulation
109. Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor
110. Estrogen regulation of a tissue factor-like procoagulant in the immature rat uterus
111. Transforming growth factor β mediates the progesterone suppression of an epithelial cell metalloproteinase by adjacent stroma in human endometrium
112. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin-1 alpha and its dual block by ovarian steroids
113. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1α in human endometrial stromal cells
114. Mast cell regulation of endometrial stromal cell matrix metalloproteinase: A mechanism underlying menstruation